Press Releases July 2, 2026 05:00 PM

Seer Announces Receipt of Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.

Seer, Inc. Receives Unsolicited Acquisition Proposal from CEO Offering Cash and Contingent Value Rights

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
SEER

Seer, Inc., a Nasdaq-listed proteomics company, announced receiving an unsolicited and non-binding acquisition proposal from its Chair and CEO, Omid Farokhzad, M.D. The proposal offers $2.45 per share in cash plus two separate contingent value rights for all outstanding shares of Class A common stock. A Special Committee of independent directors will evaluate the proposal and any alternatives, with assistance from independent financial and legal advisors. No immediate action is required from stockholders.

Seer Announces Receipt of Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.
SEER
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Unsolicited acquisition proposal made by Seer's CEO Omid Farokhzad, M.D., offering $2.45 per share plus contingent value rights.
  • Seer's Board has formed a Special Committee of independent directors to evaluate the proposal and advise on the best course of action.
  • Seer is a pioneering proteomics company providing research-use products with advanced proprietary technology impacting biotech and pharmaceutical research sectors.

REDWOOD CITY, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it has received an unsolicited, non-binding proposal from Omid Farokhzad, M.D., Seer’s Chair and Chief Executive Officer, to acquire all of the outstanding shares of Seer’s Class A common stock for $2.45 per share in cash plus two separate contingent value rights (the “Proposal”). The full text of the letter received from Farokhzad, M.D., outlining the Proposal will be included on a Form 8-K filing made by Seer.

Seer’s Board of Directors will establish a Special Committee consisting solely of independent directors. The Special Committee will evaluate the Proposal and other alternatives available to Seer, and determine the course of action that it believes is in the best interests of Seer and its stockholders. The Special Committee will retain independent financial and legal advisors to assist it with its work.

No stockholder action is required at this time.

Perella Weinberg Partners LP is serving as financial advisor to Seer and Wilson Sonsini Goodrich & Rosati, Professional Corporation is serving as legal counsel.

About Seer, Inc.

Seer, Inc. (Nasdaq: SEER) sets the standard in deep, unbiased proteomics, delivering insights with a scale, speed, precision and reproducibility previously unattainable. Seer’s Proteograph® Product Suite integrates proprietary engineered nanoparticles, streamlined automation instrumentation, optimized consumables and advanced analytical software to overcome the limitations of traditional proteomic methods. Seer’s products are for research use only and are not intended for diagnostic procedures. For more information, visit www.seer.bio.

For more information, please email us at [email protected].

Forward Looking Statements

This communication contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Such forward-looking statements are based on Seer’s beliefs and assumptions and on information currently available to it on the date of this press release. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause Seer’s actual results, performance, or achievements to be materially different from those expressed or implied by the forward-looking statements. These statements include but are not limited to statements regarding the actions to be taken by the Board and the Special Committee. These and other risks are described more fully in Seer’s filings with the Securities and Exchange Commission and other documents that Seer subsequently files with the Securities and Exchange Commission from time to time. Except to the extent required by law, Seer undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

Media Contact:
Patrick Schmidt
[email protected]

Joele Frank, Wilkinson Brimmer Katcher
Eric Brielmann / Joseph Sala
(212) 355-4449

Investor Contact:
Marissa Bych
[email protected]


Risks

  • Uncertainty whether the Board and Special Committee will accept, reject, or negotiate the acquisition proposal, causing potential volatility.
  • Dependence on contingent value rights whose future value and realization are uncertain, posing execution risk.
  • General risks related to forward-looking statements including regulatory actions and market acceptance which could affect company valuation.

More from Press Releases

Terra Innovatum Appoints Smart Wires CEO Joanna Lohkamp as Independent Director Jul 2, 2026 Alarum Technologies Responds to Inquiry into Residential Proxy Networks Jul 2, 2026 VivoPower Reinforces Focus on AI Data Center Business and Provides Update on Non-Core Businesses Jul 2, 2026 Osprey Acquisition Corp. III Completes $300.15 Million Initial Public Offering Jul 2, 2026 Ero Copper to Release Second Quarter 2026 Operating and Financial Results on August 5, 2026 Jul 2, 2026